VC  Fountain Healthcare Partners

     Office Locations:

Two Docklands Central, Level 4
Guild Street, IFSC
Dublin, D01 K2C5
Phone: 353-1-5225100

Get all office locations for this firm with a National Database subscription or New York Database subscription.


  • Early
  • Expansion
  • Growth



  • Life Sciences & Healthcare
  • Medical Device



    Fountain Healthcare Partners is a spin-out group from Elan Corporation's (NYSE:ELN) New York-based corporate venture capital group. While at Elan, the team invested in over 25 life science companies, developing the next generation of products and technologies to address unmet medical needs. Fountain Healthcare Partners I fund is the largest dedicated life science venture capital fund in Ireland. The fund had a first close at 75M Euro in April 2008. Fountain's main office is in Dublin, Ireland, with a second office in New York. Specific areas of interest to Fountain are: specialty pharma, medical devices, biotechnology and diagnostics. The firm will deploy the majority of its capital in Europe with a strong focus on Ireland. Fountain will invest in private companies at all stages of development with an emphasis on companies with experienced management teams seeking capital to fund product development activities. Fountain aims to build a portfolio of 10 to 15 life science companies, allocating between 7M and 10M Euro per company over the life of the investment.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Aidan King MBA, CFA Co-Founder and Managing Partner
    Dr. Ena Prosser Ph. D Partner
    Dr. Manus Rogan Ph. D., MBA Co-Founder and Managing Partner
    Justin Lynch MBA Partner and CFO


    Recent Funding Events (trailing 12 months):







      Velicept Therapeutics



      Series B Extension


    Portfolio companies include:

        web link

        web link

      Chrono Therapeutics
        web link

      Civitas Therapeutics
        web link

      Genable Technologies
        web link

        web link

        web link

      KaNDy Therapeutics
        web link

      Mainstay Medical
        web link

      NeRRe Therapeutics
        web link

        web link

      Neurent Medical

        web link

      Opsona Therapeutics
        web link

      Palyon Medical
        web link

      Trino Therapeutics
        web link

      Velicept Therapeutics
        web link

      Vivasure Medical
        web link


    Recent News: